All posts tagged analyst
Global spine surgery devices market to grow to $14.8 billion in five years
August 27, 2012 11:13 am by Arundhati Parmar | 0 Comments Growing at a compounded annual rate of 5.1 percent, the global spine surgery devices market is set to be worth $14.8 billion in five years. The market can be divided into four segments …
Global Spinal Devices and Biologics Market to Grow 6.9% Annually
The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by
U.S. Market for Spinal Implants & VCF 2012
NEW YORK, May 9, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
U.S. Market for Spinal Implants
Orthopedic survey: U.S. knee/hip market has hit bottom
Implantable Medical Devices Market
NEW YORK, March 19, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Implantable Medical Devices Market http://www.reportlinker.com/p0187742/Implantable-Medical-Devices-Market.html
Get Hip to These Orthopedic Players
Credit Suisse We expect sales growth for Stryker of about 5% in 2011-2016, stemming from a rebound to trend-line growth in the hip and knee markets to about 3%
Orthopedic Devices Market to 2017 – Spinal Surgery and Advanced Prosthetics Products to be Major Growth Driver By Reportlinker
NEW YORK, Feb. 21, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Orthopedic Devices Market to 2017 - Spinal
NuVasive (NUVA) Shares Given New $15.00 Price Target by Kaufman Brothers Analysts
Equities research analysts at Kaufman Brothers lowered their price target on shares of NuVasive (NASDAQ: NUVA) from $21.00 to $15.00 in a research issued note to investors on Tuesday.
MAKO Surgical (MAKO) Shares Upgraded to a “Buy” Rating by Summer Street Analysts.
MAKO Surgical (NASDAQ: MAKO) was upgraded by equities research analysts at Summer Street from a “neutral” rating to a “buy” rating in a research note issued
Moody’s: U.S. medical device firms face soft organic growth prospects
By Stewart Eisenhart, Emergo Group U.S. medical device manufacturers dealing with lower market demand and rising pricing pressure will rely more on acquisitions and stock maneuverings
MAKO Surgical (MAKO) Given New $35.00 Price Target by Piper Jaffray (PJC) Analysts.
Equities research analysts at Piper Jaffray (NYSE: PJC) boosted their price target on shares of MAKO Surgical (NASDAQ: MAKO) to $35.00 in a research note to investors on Wednesday. Separately,
Relatively High EPS Growth Detected in Shares of RTI Biologics in the Health Care Supplies Industry
Dec 27, 2010 (SmarTrend(R) News Watch via COMTEX) -- Below are the top 5 companies in the Health Care Supplies industry ranked by the year-over-year expected EPS growth
Orthofix International (NASDAQ: OFIX) Upgraded to an “Outperform” Rating
Equities research analysts at Zacks Investment Research upgraded shares of Orthofix International (NASDAQ: OFIX) from a “neutral” rating to an “outperform” rating in a research note to
Goldman Neutral On Stryker (SYK)
Goldman Sachs has a Neutral rating on Stryker Corp. (NYSE: SYK) after the company announced a sale of a division. In a note sent to investors Goldman